What Caused The VERU Stock To Nose Dive On Thursday?
Stock of Veru Inc. (NASDAQ: VERU) fell -55.56% to $6.67 on Thursday following the rejection of its medicine. Which authorization has VERU been unable to secure? The U.S. Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) met yesterday to review sabizabulin for Emergency Use Authorization (EUA) in hospitalized moderate to severe COVID-19 patients […]
Pre-Market Top Losers Today
Pre-market data show Apartment Investment and Management Company (NYSE:AIV) is -6.55% lower at $4.71 after reporting that it has completed separation of Apartment Income REIT Corp. It recently closed at $5.04, fluctuating in a day’s range from $4.88 to $6.48. Scotiabank has a Sector perform rating on AIV’s shares and set a $41 price target. […]
Keep an eye on this stock: Veru Inc. (NASDAQ: VERU), the constant rise in the late hours
Veru Inc. (NASDAQ: VERU), the stock kept on staying up 16.35% to $11.28 in after-market as the biotech oncology company focusing on the development of novel prostate and breast cancer management medicines, unveils positive Phase 2 clinical trial results for the selected oral, novel selective androgen receptor (AR) targeting agent enobosarm for the treatment of […]
Keep an eye on why Veru Inc. (NASDAQ: VERU) are shares soaring above limits in the premarket?
Veru Inc. (NASDAQ: VERU), the stock jumped 21.79% to $7.74 in the premarket session after a biopharmaceutical oncology corporation focused on the production of new cancer treatment drugs, today reported high net sales and gross profit for its fourth quarter and full-year ended September 30, 2020, for fiscal 2020. 4th-quarter: YOY highlights From $8.7 million, […]
